[Recent development in the diabetes-therapy].
D001645:Biguanides / Q000097:blood; D001786:Blood Glucose; D003920:Diabetes Mellitus / Q000188:drug therapy*; D003926:Diabetic Coma / Q000188:drug therapy / Q000209:etiology; D016883:Diabetic Ketoacidosis / Q000188:drug therapy / Q000209:etiology; D005260:Female; D006801:Humans; D006944:Hyperglycemic Hyperosmolar Nonketotic Coma / Q000188:drug therapy / Q000209:etiology / Q000378:metabolism; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007773:Lactates / Q000097:blood; D008297:Male; D011247:Pregnancy; D013453:Sulfonylurea Compounds / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use
D001645:Biguanides; D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007773:Lactates; D013453:Sulfonylurea Compounds
Neuere Entwicklungen in der Diabetes-Therapie.